For decades, families and clinicians have known that physicians can miss signs and symptoms of eating disorders until the damage is severe.

The signs are not confined to one specialty. Eating disorders may surface through rapid weight loss, growth disruption, dizziness, gastrointestinal complaints, menstrual changes, electrolyte abnormalities, compulsive exercise, purging, diabetes manipulation, depression, anxiety, self-harm, or unexplained medical decline. Body mass index can appear acceptable while the body is already in danger. A patient may look articulate, functional, and medically stable until the illness becomes a crisis.

That is why medical education is crucial.

Eating disorders are not matters of vanity, lifestyle, discipline, or willpower. They are serious psychiatric and medical illnesses that can cause permanent injury and death. Yet there are no enacted federal or state laws requiring medical schools to provide eating disorder education as part of the required medical degree curriculum, much less a law specifying hours, core content, competency assessment, annual certification, and corrective action.

That absence should shock people outside the eating disorder world. It should shame people inside it.

The field has awareness. Conferences have named the problem, families have testified to it, continuing education programs have addressed pieces of it, and public campaigns have repeated the importance of early detection until the language became familiar enough to lose force. None of that requires a medical school to change its curriculum. A webinar does not create a public record of compliance. A slogan about early intervention does not ensure that future physicians learn how to recognize medical instability, refeeding risk, weight suppression, diagnostic bias, or the danger of relying on body mass index alone.

The question is no longer whether the eating disorder community understands the problem. It plainly does. The question is why that knowledge has not been converted into state-level legislation requiring medical schools to teach future physicians before patients are harmed.

Part of the answer lies in the direction of the field itself. As private equity and large treatment platforms gained influence, advocacy increasingly moved downstream toward reimbursement, coverage, parity, treatment access, residential care, and payment for services after a diagnosis had already been made. Those issues are real. Families need coverage. Patients need care. But reimbursement policy does not protect the patient whose physician was never taught how to recognize the illness in the first place.

A system focused on paying for treatment after identification leaves the first failure intact.

That is the gap the Morgan Dunn Eating Disorders Education Act is designed to close.

During the next Texas legislative session starting in January 2027, I intend to have filed the Morgan Dunn Eating Disorders Education Act. This bill requires medical degree programs in Texas to provide core instruction on eating disorders before graduation. It is not an awareness resolution, a symbolic proclamation, or a request that schools consider the subject if time allows. It establishes a minimum legal requirement: at least eight hours of instruction and at least one case-based assessment showing that a student can recognize, medically assess, and make an appropriate referral or management plan for a patient with a suspected eating disorder.

The requirement is modest. The need is not.

The instruction would include diagnostic warning signs, medical complications, starvation, malnutrition, purging, laxative misuse, compulsive exercise, binge eating, refeeding risk, screening, physical examination, laboratory evaluation, medical stabilization, urgent referral, higher levels of care, psychiatric comorbidity, weight stigma, diagnostic bias, and continuity of care. The bill also addresses patients too often missed by stereotype, including children, males, pregnant patients, patients with diabetes, patients in larger bodies, patients with disabilities, and patients from diverse racial, ethnic, and socioeconomic backgrounds.

The bill is also drafted to answer predictable objections.

1.         Medical schools will say their curriculum is crowded.

The bill preserves flexibility. Eating disorder education can be placed inside psychiatry, pediatrics, internal medicine, family medicine, emergency medicine, OB/GYN, adolescent medicine, endocrinology, nutrition, clinical skills, behavioral health, clerkships, modules, case-based learning, or an integrated course. No school is forced to create a freestanding class unless it chooses to do so.

2.         Medical educators may say legislators should not dictate curriculum.

The bill does not dictate pedagogy. Faculty governance remains intact. Schools control placement, sequencing, method, assessment, and faculty assignment. The Legislature sets the public safety floor.

3.         Institutions may worry about liability.

The bill expressly avoids creating a private cause of action, a new professional standard of care, or a new evidentiary rule. It is an education mandate, not a litigation trap.

4.         Administrators may resist reporting.

The requirement is limited. Schools must certify compliance, identify where the instruction appears, state the approximate number of instructional hours, and describe how completion or competency is assessed. A school that falls short receives notice and an opportunity to correct the problem.

5.         Legislators may presume the bill creates a new state expense.

That concern misunderstands the design. The bill does not create a new agency, hire inspectors, fund a grant program, purchase a proprietary curriculum, build a treatment network, or create a state-funded training vendor. Compliance would occur inside medical schools that already maintain required curricula, student assessment systems, faculty governance, accreditation processes, and reporting infrastructure. The state’s role is basic accountability: receive certifications, identify noncompliance, and require correction.

Taken together, those answers make the bill difficult to caricature. It does not regulate treatment centers, expand Medicaid, create a lawsuit, or attempt to repair the entire eating disorder system through one statute. The demand is narrower and harder to evade. Texas medical schools may decide how to teach the material, but they should not be permitted to graduate future physicians without baseline training in illnesses they are certain to encounter.

Sadly, the larger obstacle may come from the eating disorder ecosystem itself. That indictment belongs in the open.

For years, organizations with platforms, donors, clinicians, researchers, treatment providers, and lobbyists could have drafted model legislation and taken it state-by-state. Instead, the public agenda too often remained in the safer territory of awareness, resources, messaging, and reimbursement. The result is a field that can describe missed diagnosis in detail while leaving medical schools under no legal obligation to teach future physicians how to prevent it.

This is not a lack of compassion. It is a failure of legislative will.

The Morgan Dunn Eating Disorders Education Act changes the question. Should a medical student be allowed to graduate in Texas without required instruction on eating disorder warning signs, medical complications, refeeding risk, medical instability, appropriate referral, and the dangers of relying on body mass index alone?

If the answer is no, the case for the bill follows.

Texas is the right place to start. The state has already recognized through recent health and nutrition legislation that medical education is a legitimate site for prevention. Eating disorder education belongs in that same frame. Physicians should be able to counsel patients about nutrition, diabetes, metabolic health, exercise, cardiovascular risk, and obesity. But they must also know when weight loss is not health, when restriction is not discipline, when exercise is not recovery, when body size conceals danger, and when a nutrition message can worsen a psychiatric illness.

There is no contradiction between prevention and eating disorder education. The contradiction lies in teaching future physicians about nutrition while leaving them underprepared to recognize starvation, purging, weight suppression, refeeding risk, and medical instability.

Eight hours will not fix the eating disorder treatment system. It will not solve insurance denials, provider shortages, hospital failures, residential treatment problems, or the divide between psychiatric and medical care.

But it can change the first medical encounter.

A physician who has been taught what to look for is more likely to recognize danger, ask the right questions, assess medical risk, and refer before the window for intervention closes. That is the purpose of the Morgan Dunn Eating Disorders Education Act. It asks Texas to not tolerate one indefensible failure: future physicians graduating without required training in illnesses that can permanently injure or kill patients when missed.

That should not be controversial. It should already be law.

[For a copy of the proposed bill, contact me. I welcome all comments and ways we can make the bill even stronger.]

The eating disorder field has spent decades asking families to trust it. Trust the treatment center. Trust the intake coordinator. Trust the website. Trust the words “evidence based.” Trust the branded clinical model. Trust the promise that the program knows what it is doing because the patient is too sick, the parents are too frightened, and the stakes are too immediate for careful comparative shopping.

But trust is not a standard of care. And neither are marketing, credentials, nor an impactful website. In a medical and psychiatric illness with substantial mortality risk, high relapse rates, serious medical complications, and profound psychiatric comorbidity, the absence of enforceable, generally accepted standards of care is not a theoretical defect. It is an operating condition that places patients in danger.

The eating disorder community has long understood the problem, even when it has not solved it. In 2008, the Academy for Eating Disorders Credentialing Task Force produced draft recommendations for residential and inpatient eating disorder program accreditation. Some of the most respected, knowledgeable professionals participated in this collaboration.

The document did not read like an aspirational brochure. It read like a blueprint for patient protection. It called for standards in assessment and treatment planning, treatment delivery, quality improvement, specialized protocols, outcome measurement, and accreditation. Its stated purposes were to safeguard patients and families seeking inpatient and residential care, improve the quality of care offered by programs, and provide a benchmark for third party payers. That language is important. It shows that the field knew, at least by then, that eating disorder treatment required more than general mental health licensure and more than ordinary institutional accreditation.

The AED standards also identified the core duties that any serious eating disorder program should recognize. Screening and intake should assess medical stability, psychiatric status, nutritional status, substance use, special needs, and developmental appropriateness. Admission should be a comprehensive interdisciplinary process involving medical, psychiatric, psychological, nutritional, and biopsychosocial assessment. Treatment planning should be timely, documented, individualized, and regularly reviewed. Continuity of care should include prompt communication with appropriate providers. Discharge planning should begin at admission and include specific follow up care. Treatment delivery should include psychological, medical, nutritional, and psychiatric care. Programs should accurately describe their licensure, staffing, levels of medical care, treatment team composition, emergency protocols, costs, insurance participation, treatment duration, discharge criteria, staff qualifications, and continuing education. Outcomes should be measured, not guessed. Quality improvement should be ongoing, documented, and tied to actual patient results.

The field knew what a safety framework looked like. It knew patients needed medical screening, physician access, psychiatric care, nutrition expertise, discharge planning, family involvement, trained staff, outcome measurement, and transparent program information. It knew residential and inpatient programs were not ordinary therapy offices with beds. They were controlled treatment environments for patients with complex medical and psychiatric illnesses. Yet these standards were abandoned.  They were never adopted nor enforced. And that is the indictment.

Building up to 2008.

This was before the Mental Health Parity Act of 2008 was passed into law. It was before the Affordable Care Act was enacted. It was before the scourge of COVID. It was also largely before the private equity gold rush into the eating disorder industry began.

When a field lacks generally accepted standards of care, it does not become more flexible. It becomes less accountable. Every treatment center can claim excellence. Every program can call itself evidence based. Every operator can define “appropriate care” around its own staffing model, payer contracts, census pressures, and clinical philosophy. A family trying to decide where to send a medically fragile child or adult is left to compare slogans. A physician trying to refer a patient is forced to rely on reputation, relationships, and sales materials. An insurer can exploit ambiguity by denying care as unnecessary. A treatment center can exploit ambiguity by selling care as indispensable. The patient is then caught between two industries, each invoking medical necessity when it serves its financial interest.

The phrase “evidence-based treatment” illustrates the collapse. In any responsible medical field, evidence-based care should mean that a treatment is supported by research, delivered with fidelity, matched to diagnosis and level of care, monitored for safety, and evaluated by outcomes. In eating disorder treatment, the phrase has too often become a branding device. It may refer to CBT, DBT, FBT, exposure work, nutrition rehabilitation, medical monitoring, group therapy, experiential therapy, or a proprietary blend of whatever the program happens to offer.

Without a standard which requires programs to identify which treatment is being used, why it is appropriate, who is trained to deliver it, how fidelity is monitored, and what outcomes are achieved, “evidence based” becomes a label detached from evidence.

The harm is not semantic. Eating disorders kill. They injure. They produce cardiac instability, electrolyte abnormalities, endocrine disruption, bone loss, gastrointestinal complications, renal stress, refeeding risk, suicidality, and profound psychiatric comorbidity. They also deceive systems that rely on visible severity. A patient can appear medically stable until the lab work, EKG, weight trajectory, purging history, exercise behavior, or refeeding risk says otherwise. A patient can be in a larger body and still be medically unstable. A patient can be “normal weight” and dying. A patient can be discharged because insurance will not pay, retained because a bed must be filled, stepped down because the program has no capacity, or admitted because the program has capacity even when a different level of care would be safer.

The absence of standards increases mortality risk because it removes the guardrails that prevent predictable harm. Certainly, the lack of standards does not cause every death. It does not explain every bad outcome. But it allows dangerous variation in medical screening, level of care decisions, staff training, treatment planning, discharge readiness, and continuity of care. In a lethal illness, dangerous variation is not a neutral administrative problem. It is a patient safety failure.

The mortality problem is compounded by misunderstanding. Culturally, eating disorders are still often reduced to vanity, dieting, thinness, control, adolescence, or female distress. That public misunderstanding persists partly because the professional system has not spoken with one disciplined voice. If the field itself cannot agree on what competent care requires, it cannot expect legislators, medical schools, insurers, journalists, families, or courts to understand the illness with precision. Fragmentation creates confusion. Confusion creates delay. Delay creates medical deterioration. In the space between first symptoms and competent intervention, patients become sicker.

The legal system has already exposed the danger of this absence. In the behavioral health coverage battles surrounding generally accepted standards of care, eating disorders should have been central. Yet when courts and insurers search for recognized standards, eating disorder specific standards have often appeared fragmented, inconsistent, or conspicuously absent from the sources treated as authoritative. That absence sends a devastating message. The illness is deadly enough to require intensive treatment, expensive enough to bankrupt families, complex enough to require interdisciplinary care, but not organized enough to present one enforceable standard to the systems that control access and accountability.

Nor did private equity create this issue. It simply entered a disorderly field and found opportunity.

That distinction matters. The eating disorder field’s failure to establish enforceable standards predated much of the private equity consolidation. But once investment capital entered the residential and intensive treatment market, the absence of standards became commercially useful. A PE backed platform benefits from scalability. Scalability requires replicable operations, predictable margins, payer strategy, labor control, census management, and brand extension. In a field with enforceable clinical standards, those pressures collide with mandatory staffing, outcome reporting, medical coverage, training, supervision, discharge criteria, and transparent patient safety obligations. In a field without enforceable standards, those pressures can be converted into business judgment.

The AED standards make the private equity question sharper, not softer. By 2008, the field had articulated the need for eating disorder specific accreditation, prompt medical screening, interdisciplinary assessment, four core treatment components, nutritional rehabilitation goals, trained staff, continuing education, transparent financial information, discharge planning, quality improvement, and outcome measurement. Any serious investor entering or expanding in the eating disorder treatment market after that point had industry notice that residential and inpatient eating disorder care required specialized safeguards. The blueprint existed. The failure was not a lack of imagination. It was a lack of enforcement.

Measured against those standards, private equity’s role was not merely ownership. It was the commercialization of ambiguity. PE backed entities could acquire respected clinical brands, consolidate markets, add locations, advertise comprehensive care, pursue higher levels of reimbursement, and present themselves as national solutions without being forced to prove standardized outcomes across the platform. They could market compassion while operating under financial structures that reward growth, utilization, and eventual sale. They could describe themselves as evidence based without submitting to a universally accepted, independently audited eating disorder standard that measured whether the care advertised was the care delivered.

This is also why standards are important. Standards do not guarantee recovery. They do not eliminate clinical judgment. They do not reduce complex human beings to checklists. Properly designed, they do the opposite. They preserve clinical judgment by defining the minimum conditions under which judgment can be trusted. They require that a patient be medically assessed before placement. They require that a program be honest about its capabilities. They require that treatment be individualized, documented, and reviewed. They require that medical, psychiatric, psychological, and nutritional care all exist in fact, not only in marketing. They require that programs measure outcomes in a way that survives scrutiny. They make it harder for a center to sell a level of care it cannot safely provide. They make it harder for an insurer to deny a level of care the patient medically needs. They give families a way to distinguish treatment from theater.

The eating disorder community has paid a severe price for its failure to impose those minimum conditions. Families have been left to investigate facilities while in crisis. Patients have been moved through levels of care without clear, enforceable criteria. Clinicians have been forced to operate in a landscape where “specialist” can mean rigorous training or little more than self- selection. Payers have been able to exploit inconsistency. Treatment centers have been able to exploit fear. Private equity has been able to exploit both.

The result is a field that too often asks for deference without submitting to discipline. It asks insurers to pay for care while failing to create uniform proof of what competent care requires. It asks families to trust programs while permitting those programs to define their own excellence. It asks physicians to refer into higher levels of care while failing to ensure that those levels of care meet eating disorder specific standards. It asks the public to understand eating disorders as serious medical and psychiatric illnesses while tolerating a treatment marketplace that sometimes behaves as though seriousness can be inferred from price.

Purportedly, this topic has been discussed on numerous occasions by various organizations and individuals. On a few occasions, the topic has even gone past the discussion stage. In 2022, the American Psychiatric Association drafted new Practice Guidelines for the Treatment of Eating Disorders. On February 27, 2023, the APA announced it had adopted these guidelines. But there was a proviso. The press release also stated, “APA’s own “Proper Use of Guidelines” section says the guidelines are not a statement of the standard of care, do not mandate a particular course of medical care, do not substitute for clinician judgment, and are voluntary.”

In late 2025, the DSM Steering Committee proposed new eating disorder severity guidelines to be adopted and included in the DSM-V-TR or the next derivation of the DSM.  Again, the warning language appears, The previously mentioned limitations apply equally to this proposal.

Effectively meaning … there has been some discussions. But, no effective, collaborative, broad-based action. Talk? Some. Solutions? None.

The solution is not another voluntary badge. It is not another proprietary credential. It is not another conference panel, white paper, or consensus statement that can be ignored by the next operator with a marketing budget. The solution is enforceable, eating disorder specific standards of care tied to accreditation, licensure, reimbursement, outcome reporting, and medical education. The standards must require medical risk assessment, refeeding competence, interdisciplinary treatment, trained staff, transparent levels of care, family involvement where appropriate, discharge planning, continuity of care, independent outcome measurement, and external accountability. They must apply to nonprofit programs, academic programs, independent centers, and PE backed platforms alike. They must be forward thinking taking into account the seismic changes which have occurred in the last five years impacting eating disorders.

The field does not need to start from scratch. The AED standards showed the beginning of the map. Later guidelines and center of excellence proposals added other pieces. The scientific literature has expanded. The public burden data have become harder to ignore. The litigation record has grown. Families have told the truth at great cost. The missing ingredient is not knowledge. It is institutional will.

An eating disorder treatment system without generally accepted standards of care is not a system. It is a marketplace. In that marketplace, the sickest patients are the least able to judge quality, the most desperate families are the easiest to persuade, the most expensive care is not always the most effective, and the most polished brands are not always the safest. That is not medicine. That is exposure.

The eating disorder community must decide whether it exists to protect patients or to protect the institutions that claim to serve them. If it chooses patients, it must accept enforceable standards, transparent outcomes, real accountability, and scrutiny of financial structures that place growth over care. If it refuses, then the verdict writes itself: the system knew the danger, possessed the tools to reduce it, and chose fragmentation over protection.

Dr. Jennifer Gaudiani’s first book, Sick Enough became one of the most influential medical texts on eating disorders for a mixed audience of clinicians, patients and families. Her recent Second Edition considerably expands its reach. It is broader in diagnostic scope, more explicit in its rejection of weight stigma, and more attentive to populations historically marginalized within eating disorder discourse, patients in larger bodies, those with ARFID or atypical anorexia, athletes, neurodivergent individuals and others.

The second edition is a substantial, clinically ambitious and humane book. This is an updated guide with a wealth of information for patients, families, and clinicians. It has an expanded coverage of weight-inclusive care, “unmeasurable” medical problems such as Positional Orthostatic Tachycardia Syndrome (POTS) and Mast Cell Activation Syndrome (MCAS) and includes specific populations such as athletes, people in perimenopause, and those with PTSD or ADHD.

Its table of contents also shows a broader scope than a narrow anorexia only manual. The Second Edition covers purging, BED, ARFID, atypical anorexia, recovery and several special populations.

It is one of the strongest medically oriented eating disorder books for a mixed audience. Especially if the reader wants a text that combines clinical seriousness with anti-stigma framing. Its greatest strength is that it repeatedly emphasizes that eating disorders are medically dangerous across body sizes and presentations. However, one of its limitations is that it can be too expansive, too clinician-shaped, and at times too structurally diffuse for readers who want either a purely patient facing guide or a tightly organized medical handbook.

What the book does very well

The Second Edition directly attacks the “not sick enough” myth. This is the book’s central moral and medical achievement. Dr. Gaudiani makes the case that eating disorders are not validated by emaciation alone and that serious risk can exist in larger bodies, in atypical anorexia, in purging disorders, and in undernutrition that is not socially legible. The Second Edition’s explicit emphasis on weight stigma and weight inclusive philosophy is one of its defining strengths.

That matters because many books on eating disorders still smuggle in a hierarchy of seriousness. Sick Enough pushes against that hierarchy. It is corrective in the best sense, not merely compassionate, but clinically corrective.

The book also bridges medicine and lived experience better than most clinician authored books. The book emphasizes case presentations, stories, metaphors, practical strategies, and approachable science. That combination seems to be the key to the book’s reputation. An independent professional reviewer noted that Dr. Gaudiani combines expertise with a compassionate tone and keeps the book accessible without drowning newer readers in jargon.

This is important because eating disorder medicine can quickly become alienating. A text can be medically accurate yet useless to frightened patients or exhausted families. Dr. Gaudiani appears to avoid that trap by translating physiology into understandable language without trivializing it.

The table of contents shows a book that does not stop at restrictive anorexia. It includes chapters on purging, BED, ARFID, atypical anorexia, recovery, neurodiversity, diabetes, athletes/REDs, males, gender and sexual minorities, sexual and reproductive health, substance use, older age, and gastrointestinal or autonomic complications.

That breadth makes it unusually useful in real world practice where some patients rarely present as textbook stereotypes. The Second Edition seems designed to reflect the heterogeneity of eating disorders rather than forcing everyone into one familiar clinical script.

The Second Edition explicitly includes a section on “The Unmeasurables,” including MCAS and POTS. Whether every reader will agree with the framing, this signals one of the book’s core virtues. It approaches in a professional manner, the messy borderlands of eating disorder medicine where symptoms may be debilitating even when medicine has not produced neat explanatory boxes.

That gives the book emotional and clinical credibility. Patients with complicated, long-standing illness often feel erased by handbooks that only recognize what fits clean laboratory or diagnostic boundaries.

A number of medical treatises are technically solid but ethically thin. Sick Enough seems to understand that care is not just about identifying bradycardia, electrolyte derangement, endocrine suppression, or GI dysfunction. It is also about how bias delays treatment. The weight stigma material is not simply ornamental. That makes the book more than a manual. It is also an intervention into how clinicians think.

Room for Improvement or Greater Clarity

As with all books, papers, studies and treatises there are areas for greater explanation and clarity.

The organization of the Second Edition may frustrate readers who want a classic systems-based handbook. One independent review from a dietitian praised the book but made a sharp structural criticism, that it did not organize material primarily by body system, so a reader trying to track for example, cardiovascular or GI consequences across diagnoses may need to jump between chapters.

That is a meaningful weakness. For a clinician in a hurry or a student trying to build a clean mental map, a systems based structure can be more efficient. Dr. Gaudiani’s presentation-by-presentation approach may feel more human and clinically realistic, but it is not always the fastest for cross-referencing.

The Second Edition also may be too medical for some patients and too general for some specialists. This is a classic hybrid text problem. By trying to serve patients, loved ones, and clinicians at once, the book likely lands a little imperfectly for each subgroup. For patients early in illness or recovery, the sheer amount of medical detail may feel overwhelming. For subspecialists already steeped in eating disorder medicine, some sections may read as broad synthesis rather than cutting edge dispute. That does not make the book weak. It makes it broad. But broad books inevitably trade some depth for reach.

One of Dr. Gaudiani’s strengths is having a strong clinical voice. The downside of that voice, in any physician authored guide, is that it can sometimes produce a subtle asymmetry. The reader is being expertly guided, but nonetheless guided. For some readers, especially those wary of medical paternalism, this can feel comforting; for others, it can feel managed.

There are also some topic choices which may invite debate. [Debate has never been a weak spot for Dr. Gaudiani.] The inclusion of conditions such as MCAS and POTS under “unmeasurables” will resonate deeply with some readers and prompt skepticism from others, especially readers sensitive to how contested syndromes are discussed in medicine.

That is not necessarily a flaw. But it does mean the book is not purely conservative in scope. It steps into areas where interpretation, causality, and framing are complicated. Some will see that as brave and patient honoring. Others will worry it risks overextension.

Sick Enough does underscore the lethality of eating disorders and makes clear that anorexia nervosa carries the highest mortality rate of any psychiatric illness, citing markedly elevated death rates relative to healthy peers and a significant contribution from suicide. However, the book does not organize this point as a sustained comparative analysis across diagnoses. Instead, it embeds the explanation within its broader medical framework. The cumulative effects of prolonged undernutrition, multi-system physiological deterioration, and heightened suicide risk. In this way, Dr. Gaudiani establishes the mortality hierarchy clearly, but explains it implicitly through the biology of starvation and clinical risk rather than through a dedicated, diagnosis-by-diagnosis examination of mortality mechanisms.

The best features and biggest improvements in the Second Edition appear to be: a stronger emphasis on weight stigma and weight-inclusive care; broader recognition of ARFID, atypical anorexia, BED, and diverse patient groups; added treatment of neurodiversity and psychiatric complexity;  inclusion of POTS, MCAS, and complex digestive issues, and; more explicit attention to athletes, males, gender/sexual minorities, sexual and reproductive health, and older adults.

That is exactly the sort of expansion a Second Edition should make. Not just “more studies,” but a wider and more current model of who gets sick and how illness presents. The Second Edition may be structurally imperfect as a reference manual, occasionally vulnerable to being too broad for specialists and too dense for lay readers, and open to debate in some of its more complex “unmeasurable” territory.

However, it is authoritative, compassionate, modern in its anti-stigma stance, broad in diagnostic scope, and far better than most medical books at explaining why a person can be very ill without “looking sick.” It seems especially strong on translating eating disorder medicine into language usable by non-specialists.

Although not flawless, [what book is?]  it is the kind of book that can genuinely change how people understand eating disorders: medically, morally, and diagnostically.

That is rare.

Which makes the Second Edition a must read for medical and mental health professionals and not just those in the eating disorder community.